Preview

Российский журнал гериатрической медицины

Расширенный поиск

Доменный подход в ведении пожилых пациентов с сердечной недостаточностью. Настоящее и будущее

https://doi.org/10.37586/2686-8636-4-2020-313-326

Полный текст:

Аннотация

В настоящее время в мире увеличивается количество больных с хронической сердечной недостаточностью (ХСН). Так, только в России число больных с ХСН за последние десятилетия увеличилось почти в 2 раза. ХСН тесно взаимосвязана с процессами старения, которые включают клеточные и анатомические изменения сердца и сосудов. Ведение пациентов с ХСН не может не учитывать функциональный, когнитивный, эмоциональный и социальный статус пациента. Таким образом, при формировании индивидуального плана необходимо учитывать не только функциональный класс и фракцию выброса левого желудочка, но и наличие или отсутствие тех или иных гериатрических синдромов. В данной статье мы попытались посмотреть на пациента с ХСН через 4 домена: медицинское состояние, эмоциональный и когнитивный статус, физическая и социальная активность. Данный комплексный подход поможет улучшить как продолжительность, так и качество жизни пожилых пациентов.

Об авторах

М. А. Федин
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Федин Максим Александрович, врач

Москва



А. Д. Изюмов
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Изюмов Андрей Дмитриевич, врач

Москва



К. А. Ерусланова
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Ерусланова Ксения Алексеевна, младший научный сотрудник лаборатории сердечно-сосудистого старения

Москва

телефон: +7(499)187-78-09



Ю. В. Котовская
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Котовская Юлия Викторовна, д-р мед. наук, профессор, заместитель директора по научной работе

Москва

телефон: +7(499)187-78-09



О. Н. Ткачева
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Ткачева Ольга Николаевна, д-р мед. наук, профессор, директор Российского геронтологического научно-клинический центра

Москва

телефон: +7(499)187-64-67



Список литературы

1. Benjamin E.J., Blaha M.J., Chiuve S.E., et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 2017; 135: e146–603.

2. Engel G.L. The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129–36.

3. Chamberlain A.M., St Sauver J.L., Gerber Y., et al. Multimorbidity in heart failure: a community perspective. Am J Med 2015; 128: 38–45.

4. Dunlay S.M., Roger V.L., Redfield M.M. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2017; 14: 591–602.

5. Paulus W.J., Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013; 62: 263–71.

6. Mentz R.J., Kelly J.P., von Lueder T.G., et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 2014; 64: 2281–93.

7. Shah K.S., Xu H., Matsouaka R.A., et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol 2017; 70: 2476–86.

8. Cherubini A., Oristrell J., Pla X., et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 2011; 171: 550–6.

9. Wong C.Y., Chaudhry S.I., Desai M.M., Krumholz H.M. Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med 2011; 124: 136–43.

10. Yancy C.W., Jessup M., Bozkurt B., et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 2017; 70: 776–803.

11. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147–239.

12. Freeland K.N., Thompson A.N., Zhao Y., Leal J.E., Mauldin P.D., Moran W.P. Medication use and associated risk of falling in a geriatric outpatient population. Ann Pharmacother 2012; 46: 1188–92.

13. Jyrkkä J., Enlund H., Lavikainen P., Sulkava R., Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2011; 20: 514–22.

14. Marcum Z.A., Amuan M.E., Hanlon J.T., et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc 2012; 60: 34–41.

15. Dai X, Hummel S.L., Salazar J.B., Taffet G.E., Zieman S., Schwartz JB. Cardiovascular physiology in the older adults. J Geriatr Cardiol 2015; 12: 196–201.

16. O’Mahony D., O’Sullivan D., Byrne S., O’Connor M.N., Ryan C., Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213–8.

17. Reeve E., Gnjidic D., Long J., Hilmer S. A systematic review of the emerging definition of ’deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015; 80: 1254–68.

18. Kalogianis M.J., Wimmer B.C., Turner J.P., et al. Are residents of aged care facilities willing to have their medications deprescribed? Res Social Adm Pharm 2016; 12: 784–8.

19. Punnoose L.R., Givertz M.M., Lewis E.F., Pratibhu P., Stevenson L.W., Desai A.S. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail 2011; 17: 527–32.

20. Eaton C.B., Pettinger M., Rossouw J., et al. Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail 2016; 9: e002883.

21. Sundström J., Bruze G., Ottosson J., Marcus C., Näslund I., Neovius M. Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment. Circulation 2017; 135: 1577–85.

22. Shimada Y.J., Tsugawa Y., Brown D.F., Hasegawa K. Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, selfcontrolled series. J Am Coll Cardiol 2016; 67: 895–903.

23. Kitzman D.W., Brubaker P., Morgan T., et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2016; 315: 36–46.

24. Forman D.E., Santanasto A.J., Boudreau R., et al. Impact of incident heart failure on body composition over time in the Health, Aging, and Body Composition study population. Circ Heart Fail 2017; 10: e003915.

25. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050–3.

26. Gaggin H.K., Belcher A.M., Gandhi P.U., Ibrahim N.E., Januzzi J.L. Jr. Serial echocardiographic characteristics, novel biomarkers and cachexia development in patients with stable chronic heart failure. J Cardiovasc Transl Res 2016; 9: 429–31.

27. Rozentryt P., von Haehling S., Lainscak M., et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle 2010; 1: 35–42.

28. Baumgartner R.N., Wayne SJ., Waters D.L., Janssen I., Gallagher D., Morley J.E. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12: 1995–2004.

29. Upadhya B., Haykowsky M.J., Eggebeen J., Kitzman D.W. Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction. Curr Heart Fail Rep 2015;12: 205–14. JACC VOL. 71, NO. 17, 2018 Gorodeski et al. MAY 1, 2018:192–36 HF in the Geriatric Patient 1933

30. Saitoh M., Dos Santos M.R., Ebner N., et al. Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure. Wien Klin Wochenschr 2016; 128: 497–504.

31. Lin H., Zhang H., Lin Z., Li X., Kong X., Sun G. Review of nutritional screening and assessment tools and clinical outcomes in heart failure. Heart Fail Rev 2016; 21: 549–65.

32. Gupta D., Georgiopoulou V.V., Kalogeropoulos A.P., et al. Dietary sodium intake in heart failure. Circulation 2012; 126: 479–85.

33. Jefferson K., Ahmed M., Choleva M., et al. Effect of a sodium-restricted diet on intake of other nutrients in heart failure: implications for research and clinical practice. J Card Fail 2015; 21: 959–62.

34. Paterna S., Fasullo S., Parrinello G., et al. Shortterm effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci 2011; 342: 27–37.

35. Colin-Ramirez E., McAlister F.A., Zheng Y., Sharma S., Ezekowitz J.A. Changes in dietary intake and nutritional status associated with a significant reduction in sodium intake in patients with heart failure. A sub-analysis of the SODIUM-HF pilot study. Clin Nutr ESPEN 2016; 11: e26–32.

36. Levitan E.B., Lewis C.E., Tinker L.F., et al. Mediterranean and DASH diet scores and mortality in women with heart failure: The Women’s Health Initiative. Circ Heart Fail 2013; 6: 1116–23.

37. Lennie T.A., Moser D.K., Heo S., Chung M.L., Zambroski C.H. Factors influencing food intake in patients with heart failure: a comparison with healthy elders. J Cardiovasc Nurs 2006; 21: 123–9.

38. Bonilla-Palomas J.L., Gámez-López A.L., Castillo-Domínguez JC., et al. Nutritional intervention in malnourished hospitalized patients with heart failure. Arch Med Res 2016; 47: 535–40.

39. Cannon J.A., Moffitt P., Perez-Moreno A.C., et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 2017; 23: 464–75.

40. Roberts R., Knopman D.S. Classification and epidemiology of MCI. Clin Geriatr Med 2013; 29: 753–72.

41. Havakuk O., King K.S., Grazette L., et al. Heart failure-induced brain injury. J Am Coll Cardiol 2017; 69: 1609–16.

42. Patel A., Parikh R., Howell E.H., Hsich E., Landers SH., Gorodeski EZ. Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure. Circ Heart Fail 2015; 8: 8–16.

43. Malhotra A., Orr J.E., Owens R.L. On the cutting edge of obstructive sleep apnoea: where next? Lancet Respir Med 2015; 3: 397–403.

44. Kindermann I., Fischer D., Karbach J., et al. Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail 2012; 14: 404–13.

45. Yzeiraj E., Tam D.M., Gorodeski E.Z. Management of cognitive impairment in heart failure. Curr Treat Options Cardiovasc Med 2016; 18: 4.

46. Albert N.M., Barnason S., Deswal A., et al. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail 2015; 8: 384–409.

47. Canessa N., Castronovo V., Cappa S.F., et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med 2011; 183: 1419–26.

48. Rizzi M.A., Torres Bonafonte O.H., Alquezar A., et al. Prognostic value and risk factors of delirium in emergency patients with decompensated heart failure. J Am Med Dir Assoc 2015; 16: 799.e1–6.

49. Oh E.S., Fong T.G., Hshieh T.T., Inouye S.K. Delirium in older persons: advances in diagnosis and treatment. JAMA 2017; 318: 1161–74.

50. Sokoreli I., de Vries J.J., Pauws S.C., Steyerberg E.W. Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail Rev 2016; 21: 49–63.

51. Sullivan M.D., Newton K., Hecht J., Russo J.E., Spertus JA. Depression and health status in elderly patients with heart failure: a 6-month prospective study in primary care. Am J Geriatr Cardiol 2004; 13: 252–60.

52. Yesavage J.A. Geriatric depression scale. Psychopharmacol Bull 1988; 24: 709–11.

53. Alves T.C., Busatto G.F. Regional cerebral blood flow reductions, heart failure and Alzheimer’s disease. Neurol Res 2006; 28: 579–87.

54. Suzuki H., Matsumoto Y., Ota H, et al. Hippocampal blood flow abnormality associated with depressive symptoms and cognitive impairment in patients with chronic heart failure. Circ J 2016; 80: 1773–80.

55. Garcia S., Spitznagel M.B., Cohen R., et al. Depression is associated with cognitive dysfunction in older adults with heart failure. Cardiovasc Psychiatry Neurol 2011; 2011: 368324.

56. Blumenthal J.A., Babyak M.A., O’Connor C., et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HFACTION randomized trial. JAMA 2012; 308: 465–74.

57. O’Connor C.M., Jiang W., Kuchibhatla M., et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHARTCHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010; 56: 692–9.

58. Reynard A.K., Butler R.S., McKee M.G., Starling R.C, Gorodeski EZ. Frequency of depression and anxiety before and after insertion of a continuous flow left ventricular assist device. Am J Cardiol 2014; 114: 433–40.

59. Forman D.E., Arena R., Boxer R., et al. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2017; 135: e894–918.)

60. Tkacheva O.N., Kotovskaya Y.V., Runikhina N.K., Frolova E.V., Naumov A.V., Vorobyeva N.M., Ostapenko V.S., Mkhitaryan E.A., Sharashkina N.V., Tyukhmenev E.A., Pereverzev A.P., Dudinskaya E.N. Clinical guidelines on frailty. Russian Journal of Geriatric Medicine. 2020; (1): 11–46. (In Russ.) https://doi.org/10.37586/2686-8636-1-2020-11-46

61. Tkacheva O.N., Kotovskaya Y.V., Runikhina N.K., Frolova E.V., Naumov A.V., Vorobyeva N.M., Ostapenko V.S., Mkhitaryan E.A., Sharashkina N.V., Tyukhmenev E.A., Pereverzev A.P., Dudinskaya E.N. Clinical guidelines frailty. Part 2. Russian Journal of Geriatric Medicine. 2020; (2): 115–130. (In Russ.) https://doi.org/10.37586/2686-8636-2-2020-115-130

62. Joseph S.M., Rich M.W. Targeting frailty in heart failure. Curr Treat Options Cardiovasc Med 2017; 19: 31.

63. Joyce E. Frailty in advanced heart failure. Heart Fail Clin 2016; 12: 363–74.

64. Ali S., Garcia J.M. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options—a mini-review. Gerontology 2014; 60: 294–305.

65. Hegde S.M., Claggett B., Shah A.M., et al. Physical activity and prognosis in the TOPCAT trial(Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist). Circulation 2017; 136: 982–92.

66. Haykowsky M.J., Kouba E.J., Brubaker PH., Nicklas B.J., Eggebeen J., Kitzman D.W. Skeletalmuscle composition and its relation to exercise in tolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol 2014; 113: 1211–6.

67. Denfeld Q.E., Winters-Stone K., Mudd J.O., Gelow J.M., Kurdi S., Lee C.S. The prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol 2017; 236: 283–9.

68. Joyce E. Frailty and cardiovascular disease: a two-way street? Cleve Clin J Med 2018; 85: 65–8.

69. Maurer M.S., Horn E., Reyentovich A., et al. Can a left ventricular assist device in individuals with advanced systolic heart failure improve or reverse frailty? J Am Geriatr Soc 2017; 65: 2383–90.

70. Schopfer D.W., Forman D.E. Growing relevance of cardiac rehabilitation for an older population with heart failure. J Card Fail 2016; 22: 1015–22.

71. Tucker W.J., Nelson M.D., Beaudry R.I., et al. Impact of exercise training on peak oxygen uptake and its determinants in heart failure with preserved ejection fraction. Card Fail Rev 2016; 2: 95–101.

72. Reeves G.R., Whellan D.J., Duncan P., et al. Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: design and rationale. Am Heart J 2017; 185: 130–9.

73. Forman D.E., Lipsitz L.A. Syncope in the elderly. Cardiol Clin 1997; 15: 295–311.

74. Sibley K.M., Voth J., Munce S.E., Straus S.E., Jaglal SB. Chronic disease and falls in community dwelling Canadians over 65 years old: apopulationbased study exploring associations with number and pattern of chronic conditions BMC Geriatr 2014; 14: 22.

75. Tinetti M.E., Speechley M., Ginter S.F. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701–7.

76. Tinetti M.E., Kumar C. The patient who falls: “It’s always a trade-off”. JAMA 2010; 303: 258–66.

77. Tricco A.C., Thomas S.M., Veroniki A.A, et al. Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis. JAMA 2017; 318: 1687–99.

78. Steptoe A., Shankar A., Demakakos P., Wardle J. Social isolation, loneliness, and all-cause mortality in older men and women. Proc Natl Acad Sci U S A 2013; 110: 5797–801.

79. Molloy G.J., McGee H.M., O’Neill D., Conroy RM. Loneliness and emergency and planned hospitalizations in a community sample of older adults. J Am Geriatr Soc 2010; 58: 1538–41.

80. Krumholz H.M., Butler J., Miller J., et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97: 958–64.

81. Yu D.S., Lee D.T., Kwong A.N., Thompson D.R., Woo J. Living with chronic heart failure: a review of qualitative studies of older people. J Adv Nurs2008; 61: 474–83.

82. Cattan M., White M., Bond J., Learmouth A. Preventing social isolation and loneliness among older people: a systematic review of health promotion interventions. Ageing Soc 2005; 25: 41–67.

83. Luttik M.L., Jaarsma T., Veeger N., van Veldhuisen D.J. Marital status, quality of life, and clinical outcome in patients with heart failure. Heart Lung 2006; 35: 3–8.

84. Adelman R.D., Tmanova L.L., Delgado D., Dion S., Lachs MS. Caregiver burden: a clinical review. JAMA 2014; 311: 1052–60.

85. Bidwell J.T., Lyons K.S., Lee C.S. Caregiver wellbeing and patient outcomes in heart failure: a metaanalysis. J Cardiovasc Nurs 2017; 32: 372–82.

86. Thomeer M.B., Mudrazija S., Angel J.L. Relationship status and long-term care facility use in later life. J Gerontol B Psychol Sci Soc Sci 2016; 71: 711–23.

87. Boland L., Légaré F., Perez M.M., et al. Impact of home care versus alternative locations of care on elder health outcomes: an overview of systematic reviews. BMC Geriatr 2017; 17: 20.

88. Adler E.D., Goldfinger J.Z., Kalman J., Park M.E., Meier DE. Palliative care in the treatment of advanced heart failure. Circulation 2009; 120: 2597–606.

89. Lewis E.F. Assessing the impact of heart failure therapeutics on quality of life and functional capacity. Curr Treat Options Cardiovasc Med 2013; 15: 425–36.

90. Joyce E., Chung C., Badloe S., et al. Variable contribution of heart failure to quality of life in ambulatory heart failure with reduced, better, or preserved ejection fraction. J Am Coll Cardiol Hf 2016; 4: 184–93.

91. Tinetti M.E., Naik A.D., Dodson J.A. Moving from disease-centered to patient goals-directed care for patients with multiple chronic conditions: patient value-based care. JAMA Cardiol 2016; 1: 9–10.

92. Allen L.A., Stevenson L.W., Grady K.L., et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation 2012; 125: 1928–52.

93. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147–239.

94. Sidebottom A.C., Jorgenson A., Richards H., Kirven J., Sillah A. Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial. J Palliat Med 2015; 18: 134–42.

95. Afilalo J., Lauck S., Kim D.H., et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 2017; 70: 689–700.


Для цитирования:


Федин М.А., Изюмов А.Д., Ерусланова К.А., Котовская Ю.В., Ткачева О.Н. Доменный подход в ведении пожилых пациентов с сердечной недостаточностью. Настоящее и будущее. Российский журнал гериатрической медицины. 2020;(4):313-326. https://doi.org/10.37586/2686-8636-4-2020-313-326

For citation:


Fedin M.A., Izumov A.D., Eruslanova K.A., Kotovskaya Yu.V., Tkacheva O.N. Domain management as the best way of manage patient with heart failure and geriatrics syndromes. Russian Journal of Geriatric Medicine. 2020;(4):313-326. (In Russ.) https://doi.org/10.37586/2686-8636-4-2020-313-326

Просмотров: 242


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2686-8636 (Print)
ISSN 2686-8709 (Online)